Solstice will acquire Fort Lauderdale’s Element Solutions in a $14.5B cash-and-stock deal that links electronics materials with data‑center cooling and AI hardware.

Circle won final OCC approval to establish Circle National Trust, positioning USDC under federal oversight and enabling institutional custody services.

NewYork-Presbyterian and its academic partners are deploying OpenEvidence across hospitals and clinics to give clinicians research-backed answers at the point of care.

Google will flag ads created with generative AI and provide attestation tools for advertisers. Bay Area teams should audit creative and add provenance metadata now.

NewYork‑Presbyterian and Catholic Health are partnering to bring Herbert Irving clinical trials to Long Island patients, with 20 studies already available.

Milan-based Bending Spoons priced 58M shares at $29 on Nasdaq, raising about $1.7B as the stock jumped and investors priced its plan to revive AOL, Vimeo and Eventbrite.

The FDA tapped seven companies — including Eli Lilly and Regeneron — for a PreCheck pilot to speed reviews of new U.S. drug plants. The cohort includes big pharma and specialized CDMOs.

The New York Times amended its June 25 complaint, dropping a claim against OpenAI and refocusing its allegations on Microsoft in a major copyright battle.

Mount Sinai scientists identified tiny blood particles called SECmeres that carry brain‑specific RNA and outperformed standard extracellular vesicles as potential Alzheimer’s biomarkers.

SpaceX has agreed to provide Reflection AI with GB300-class compute at its Colossus campus near Memphis in a deal that could reach $6.3 billion.

Pfizer announced that CFO Dave Denton will step down Aug. 15; Cecile Guegan will serve as interim CFO while the company launches a search for a successor. The move follows several major deals that reshaped Pfizer’s balance sheet.

A Rutgers genetic survey found many city mice carry mutations that blunt commonly used poisons, complicating pest control in Brooklyn.

A New York‑led coalition of state attorneys general served OpenAI with a sweeping subpoena seeking memos on advertising, retention, data and child and senior safety as the company confirms a confidential IPO filing.